Related Experiment Video
Updated: Aug 18, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement
Mingzhou Li1, Jean G Dumesnil, Patrick Mathieu
1Research Group in Valvular Heart Diseases, Research Center of Laval Hospital/Quebec Heart Institute, Laval University, 2725 Chemin Saint-Foy, Sainte-Foy, Quebec, Canada G1V 4G5.
Objectives:
We sought to determine the impact of valve prosthesis-patient mismatch (PPM) on pulmonary arterial (PA) pressure after mitral valve replacement (MVR).
Background:
Pulmonary arterial hypertension is a serious complication of mitral valve disease, and it is a major risk factor for poor outcome after MVR. We hypothesized that valve PPM might be a determinant of PA hypertension after MVR.
Methods:
Systolic PA pressure was measured by Doppler echocardiography in 56 patients with normally functioning mitral prosthetic valves. Mitral valve effective orifice area (EOA) was determined by the continuity equation and indexed for body surface area.
Results:
Thirty patients (54%) had PA hypertension defined as systolic PA pressure >40 mm Hg, whereas 40 patients (71%) had PPM defined as an indexed EOA < or =1.2 cm(2)/m(2). There was a significant correlation (r = 0.64) between systolic PA pressure and indexed EOA. The average systolic PA pressure and prevalence of PA hypertension were 34 +/- 8 mm Hg and 19% in patients with no PPM versus 46 +/- 8 mm Hg and 68% in patients with PPM (p < 0.001). In multivariate analysis, the indexed EOA was by far the strongest predictor of systolic PA pressure.
Conclusions:
Persistent PA hypertension is frequent after MVR and strongly associated with the presence of PPM. The clinical implications of these findings are important given that PPM can largely be avoided by using a simple prospective strategy at the time of operation.
Insights
Prosthesis-patient mismatch (PPM) after mitral valve replacement (MVR) significantly increases pulmonary arterial (PA) pressure. Avoiding PPM through careful valve selection can prevent persistent PA hypertension post-MVR.
Area of Science:
- Cardiology
- Cardiac Surgery
- Biomedical Engineering
Background:
- Pulmonary arterial hypertension (PAH) is a severe complication of mitral valve disease.
- PAH is a significant risk factor for adverse outcomes following mitral valve replacement (MVR).
- Prosthesis-patient mismatch (PPM) is hypothesized to contribute to PA hypertension post-MVR.
Purpose of the Study:
- To investigate the relationship between valve prosthesis-patient mismatch (PPM) and pulmonary arterial (PA) pressure.
- To assess the impact of PPM on PA pressure after mitral valve replacement (MVR).
Main Methods:
- Systolic PA pressure was measured using Doppler echocardiography in 56 patients with functioning mitral prosthetic valves.
- Mitral valve effective orifice area (EOA) was calculated via the continuity equation and indexed to body surface area.
- PPM was defined as indexed EOA ≤ 1.2 cm²/m².
Main Results:
- 54% of patients had PA hypertension (systolic PA pressure >40 mm Hg).
- 71% of patients exhibited PPM.
- A strong correlation (r=0.64) was observed between systolic PA pressure and indexed EOA.
- Patients with PPM had significantly higher PA pressure (46±8 mm Hg) and PA hypertension prevalence (68%) compared to those without PPM (34±8 mm Hg, 19%; p<0.001).
- Indexed EOA was the strongest predictor of systolic PA pressure in multivariate analysis.
Conclusions:
- Persistent PA hypertension is common after MVR and is strongly linked to PPM.
- These findings underscore the importance of addressing PPM to improve patient outcomes.
- Utilizing a prospective strategy during surgery can largely prevent PPM.
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse I: Introduction
Mitral Stenosis IV: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse III: Nursing Management

